Somatotropin: Uses, Benefits, and HGH Therapy Explained

Summary of Key Points

Somatotropin is a form of human growth hormone used to treat conditions such as growth hormone deficiency, Turner syndrome, and muscle wasting. It plays a crucial role in stimulating growth, cell reproduction, and tissue regeneration. Somatotropin is available in various forms and strengths. Always consult your healthcare provider before starting or adjusting your dose. You can also schedule a telemedicine appointment with one of our providers to discuss your treatment options.

Names of Medication

US Brand Names: Genotropin, Humatrope, Norditropin, Omnitrope, Saizen, Zomacton

The generic name for this medication is Somatotropin. The generic name refers to the official medical name of the active ingredient, while the brand name is the commercial name. The generic name is often listed in parentheses.

Pharmacologic Category

Growth Hormone (GH)

Endocrine-Metabolic Agent

Somatotropin Dosing Guidelines

Somatotropin is prescribed for a variety of conditions, with dosage and frequency tailored to the specific condition being treated. Always follow your healthcare provider’s instructions and consult them before making any changes to your dose. If you need to speak with a healthcare provider, you can schedule a telemedicine consultation with us.

Growth Hormone Deficiency (Adults)

Initial Dose: 0.15 to 0.3 mg subcutaneously (under the skin) once daily.

Maintenance Dose: Adjust based on clinical response and IGF-1 levels, typically ranging from 0.15 to 0.75 mg daily.

Duration: Long-term treatment, as directed by your healthcare provider.

Turner Syndrome

Initial Dose: 0.375 mg/kg/week, divided into daily doses.

Duration: Treatment is usually long-term, continuing until growth is complete or as advised by your doctor.

Prader-Willi Syndrome

Initial Dose: 0.24 mg/kg/week, divided into daily doses.

Duration: Long-term treatment, with regular monitoring by your healthcare provider.

Chronic Kidney Disease

Initial Dose: 0.35 mg/kg/week, divided into daily doses.

Duration: Treatment continues until growth is complete or as directed by your healthcare provider.

Short Stature (Adults)

Initial Dose: 0.16 to 0.24 mg/kg/week, divided into daily doses.

Duration: Long-term treatment, depending on the patient’s response and growth needs.

Idiopathic Short Stature

Initial Dose: 0.37 mg/kg/week, divided into daily doses.

Duration: Treatment is typically long-term, continuing until growth is complete.

Muscle Wasting (Associated with HIV)

Initial Dose: 0.1 mg/kg subcutaneously once daily.

Duration: Treatment duration depends on the patient’s response and clinical condition.

Cachexia

Initial Dose: 0.1 mg/kg subcutaneously once daily.

Duration: Treatment duration is based on clinical response and patient needs.

Hypopituitarism

Initial Dose: 0.15 to 0.3 mg subcutaneously once daily.

Maintenance Dose: Adjust based on clinical response, typically ranging from 0.15 to 0.75 mg daily.

Duration: Long-term treatment, as directed by your healthcare provider.

Osteoporosis

Initial Dose: 0.15 to 0.3 mg subcutaneously once daily.

Duration: Treatment duration depends on the patient’s response and improvement in bone density.

Dosage Forms and Strengths

Injection, powder for solution: 5 mg, 10 mg, 12 mg, 15 mg, 20 mg

Injection, solution: 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg, 1.2 mg, 1.4 mg, 1.6 mg, 1.8 mg, 2 mg

Administration Instructions for Somatotropin

Somatotropin is typically administered as a subcutaneous injection (under the skin). Your healthcare provider will guide you on how to properly inject the medication. It is important to rotate injection sites to prevent skin irritation or damage. If you miss a dose, take it as soon as you remember, but do not double up on doses. Always follow your doctor’s instructions carefully, and if you have any questions, reach out to one of our telemedicine providers for guidance.

Contraindications for Somatotropin Use

A contraindication is a specific situation or condition where a particular treatment or medication should not be used because it may cause harm. If you have any of the following conditions, you should not take Somatotropin, as it could lead to serious complications:

1. Active Cancer: Somatotropin can stimulate cell growth, which may worsen cancer or increase the risk of recurrence.
2. Severe Illness After Surgery or Trauma: People recovering from major surgery or trauma may experience complications like increased pressure in the brain or fluid retention, which Somatotropin can exacerbate.
3. Acute Respiratory Failure: Somatotropin can cause fluid retention, which may worsen breathing problems in individuals with severe lung conditions.
4. Closed Epiphyses (in children): Somatotropin is used to promote growth in children, but it should not be used once the growth plates in the bones have closed, as it will no longer be effective.
5. Diabetic Retinopathy: This serious eye condition caused by diabetes may worsen with Somatotropin due to increased fluid retention and blood vessel growth.

Drug to Drug Interactions with Somatotropin

Somatotropin, also known as human growth hormone (HGH), can interact with other medications, potentially altering its effectiveness or increasing the likelihood of side effects. It’s important to inform your healthcare provider about all the medications you are currently taking. Some drugs that may interact with Somatotropin include:

1. Glucocorticoids (e.g., Prednisone): These medications may reduce the effectiveness of Somatotropin by counteracting its effects on growth and metabolism.
2. Insulin or Oral Diabetes Medications (e.g., Metformin): Somatotropin can influence blood sugar levels, so adjustments to diabetes medications may be necessary.
3. Estrogen (e.g., Premarin): High doses of estrogen, particularly in women undergoing hormone replacement therapy, can decrease the effectiveness of Somatotropin.
4. Cyclosporine (e.g., Neoral): Somatotropin may increase cyclosporine levels in the blood, which could raise the risk of side effects.

Somatotropin in Pregnancy: Is It Safe?

Is it safe to use Somatotropin during pregnancy? Research on the use of Somatotropin in pregnant women is limited, and it is generally not recommended unless the potential benefits clearly outweigh the risks. If you are pregnant or planning to become pregnant, it’s crucial to discuss this with your healthcare provider. They can help you evaluate the risks and benefits and determine the most appropriate course of action. You can also schedule a telemedicine appointment with one of our providers to discuss your specific situation in more detail.

Somatotropin While Breastfeeding: What You Need to Know

Is it safe to take Somatotropin while breastfeeding? There is currently insufficient data to determine whether Somatotropin passes into breast milk or if it could affect a nursing infant. If you are breastfeeding, it’s important to consult your healthcare provider before starting Somatotropin. They can help you make an informed decision based on your health needs and any potential risks to your baby.

Estimated Cost of Somatotropin Medication

The cost of Somatotropin can vary depending on the brand and dosage. Without insurance, a 30-day supply of Somatotropin using a GoodRx coupon is estimated to range between $1,000 and $5,000. Prices may differ based on the pharmacy and the specific product prescribed. Be sure to check with your pharmacy for the most accurate pricing information.

Possible Alternatives to Somatotropin

If Somatotropin is not the right option for you, there are alternative treatments and lifestyle changes that may help manage the conditions it treats. Always discuss any changes to your treatment plan with your healthcare provider, or schedule a telemedicine appointment with one of our providers to explore your options.

1. Growth Hormone Deficiency: Alternatives include other growth hormone therapies or medications that stimulate growth hormone production. Addressing underlying health conditions may also help improve growth hormone levels.
2. Turner Syndrome: In addition to growth hormone therapy, estrogen replacement therapy may help promote the development of secondary sexual characteristics and improve bone health.
3. Prader-Willi Syndrome: Alongside growth hormone therapy, managing diet, physical activity, and behavioral therapies is essential for improving quality of life.
4. Chronic Kidney Disease: Treatment may involve managing blood pressure, controlling blood sugar, and following a kidney-friendly diet. In some cases, kidney transplantation may be necessary.
5. Short Stature: Depending on the cause, treatments may include nutritional support, hormone therapies, or addressing underlying medical conditions.
6. Idiopathic Short Stature: If no underlying cause is identified, growth hormone therapy may be an option. Other treatments include monitoring growth and addressing psychosocial concerns.
7. Muscle Wasting: Treatment options may include nutritional support, physical therapy, and medications that help preserve muscle mass, such as anabolic steroids.
8. Cachexia: Managing the underlying condition (such as cancer or chronic illness), along with nutritional support and medications to stimulate appetite, may help improve symptoms.
9. Hypopituitarism: Treatment typically involves hormone replacement therapies to address specific hormone deficiencies.
10. Osteoporosis: Alternatives include medications like bisphosphonates (e.g., Alendronate), calcium and vitamin D supplements, and weight-bearing exercises to improve bone density.

Recent Updates on Somatotropin Research

Recent studies have focused on the long-term safety and effectiveness of Somatotropin, particularly in children and adults with growth hormone deficiencies. Research indicates that Somatotropin can improve growth outcomes in children and may enhance muscle mass and bone density in adults. However, ongoing studies are investigating potential risks, including an increased risk of cancer and metabolic side effects. Stay informed about new research, and discuss the latest findings with your healthcare provider during a telemedicine visit.

James Kingsley

Learn More